PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1250770
PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1250770
Hyperhidrosis Treatment Market Forecasts to 2028 - Global Analysis By Treatment Type, Disease Type, End User and By Geography
According to Stratistics MRC, the Global Hyperhidrosis Treatment Market is accounted for $616.1 billion in 2022 and is expected to reach $929.8 billion by 2028 growing at a CAGR of 7.1% during the forecast period. Excessive sweating that is not necessarily caused by heat or exertion is known as hyperhidrosis. Sweating so intensely that it soaks through your clothes or drips off your hands is possible. Sweating excessively can ruin your day and cause social anxiety and shame. Treatment for hyperhidrosis is usually effective it usually starts with antiperspirants. The rise in the prevalence of secondary hyperhidrosis disorders, as well as the increase in research and development expenditure by market participants, are significant drivers driving the growth of the hyperhidrosis treatment market.
According to a study published in the journal Scientific Reports in 2021, people who received Botox injections at four different sites reported significantly fewer signs of anxiety than those who received different treatments for the same conditions.
Market Dynamics:
Driver:
Increasing R&D activity and strategic partnerships
The most recent R&D initiatives related to the sector are gaining popularity around the world. Brickell Biotech Inc., for example, announced favourable topline results from the Phase 3 pivotal Cardigan I and Cardigan II studies that assessed sofpironium bromide gel, 15% as a once-daily topical formulation in patients with primary axillary hyperhidrosis this increases market growth. Patients suffering from hyperhidrosis want home treatments that provide reasonable and beneficial relief, particularly for children. However strategic partnerships and collaborations between various industry companies and organisations are assisting in market growth.
Restraint:
High cost
The high cost of treatment procedures stifles market expansion. Patients frequently fail to adopt these high-end treatment alternatives due to a lack of acceptable payment plans and special considerations by organisations, which have a significant impact on their health. As a result, this is an essential constraint that must be addressed. Moreover, the treatment may lead to the increased compensatory sweating which hampers the market growth.
Opportunity:
Rise in hyperhidrosis case
The prevalence of this illness in the United States is estimated to be around 3%. Hyperhidrosis can cause emotional, psychological, social, and vocational difficulties. As a result, the increased prevalence of hyperhidrosis is predicted to enhance demand for therapy and consequently market growth. Onabotulinumtoxin A can be used to treat excessive sweating in the armpits, hands, feet, head, and face, as well as other relatively tiny body locations. Botox has been demonstrated to significantly reduce perspiration by 82-87%. The benefits appear 2 to 4 days after treatment, with the full results evident within two weeks thereby propelling the market.
Threat:
Side effects
Botox is connected with a number of adverse effects. Consequences such as muscle weakness, eye problems, and breathing difficulties are significantly hurting patients and stifling market expansion. Furthermore, potential adverse effects include dry mouth, impaired vision, and bladder issues. Excessive sweating on the back, belly, thighs, or lower legs is the most unpleasant side effect which hampers the market.
Covid-19 Impact
The COVID-19 pandemic is expected to slow the growth of the global market for hyperhidrosis remedies. During the pandemic, however, many individuals treated their ailments via self-medication or other alternative ways, despite warnings to keep social isolation. During the pandemic, individuals with hyperhidrosis had a disproportionately greater risk of depression, particularly among female patients, and some of these patients reported difficulty accessing therapy.
The Surgical treatments segment is expected to be the largest during the forecast period
The Surgical treatments segment is estimated to have a lucrative growth, due to its specialist sweat test that can assist establish if the amount of perspiration your body produces is within normal limits. Medical professionals addressed hyperhidrosis with nonsurgical approaches such as antiperspirants, muscle relaxing injections, and medicines. These treatments only provide short relief from symptoms. Using a small endoscope and a harmonic blade, remove a segment of the hyperactive nerve. This clever blade vibrates at high frequencies and produces little heat, protecting adjacent nerves. Surgery provides long-term relief from excessive sweating. Surgical hyperhidrosis less invasive incisions of less than three millimetres, improved nerve vision for more precise surgery, reduced surgical pain, a shorter recovery period, and no problems there by encouraging in the market growth.
The Primary focal hyperhidrosis segment is expected to have the highest CAGR during the forecast period
The Primary focal hyperhidrosis segment is anticipated to witness the fastest CAGR growth during the forecast period, due to antiperspirant on prescription doctor may prescribe an antiperspirant containing aluminium chloride. Medication that blocks nerves, prescribed creams and wipes are used to effectively treat the axillae, palms, and soles are commonly affected by primary focal hyperhidrosis. Other locations that may be affected include the face, scalp, inguinal, and inframammary areas. Primary hyperhidrosis is produced by incorrect nerve signals, which cause eccrine sweat glands to overwork. It typically affects the palms, soles, underarms, and occasionally the face.
Region with largest share:
North America is projected to hold the largest market share during the forecast period owing to a majority of the worldwide hyperhidrosis treatment market share in 2021 and is predicted to continue dominant during the forecast period. This is due to technological advances in hyperhidrosis treatment, a elevated incidence of disease, and the availability of critical and robust medical infrastructure in the region to see significant growth as the patient population grows, healthcare infrastructure develops, and investment initiatives in the region expand.
Region with highest CAGR:
Europe is projected to have the highest CAGR over the forecast period, owing to The high frequency of primary and secondary hyperhidrosis in the region will increase treatment uptake. Because of the high prevalence, several therapies, such as over-the-counter aluminium chloride hexahydrate 20.0% in the region, have seen greater use. Such predominance will enhance demand for product consumption, resulting in market expansion. The increasing burden of primary hyperhidrosis, cancer, and cardiovascular problems, rises in secondary hyperhidrosis, technological improvements, and the existence of important market participants in the region are all contributing to the growth.
Key Players in the market
Some of the key players profiled in the Hyperhidrosis Treatment Market include Brickell Biotech Inc, Eli Lilly and Company, AbbVie Inc, 1315 Capital, Merz Pharma, Dermadry Laboratories Inc, Dermata Therapeutics Inc., Advin Health Care, Dermavant Sciences Inc, TheraVida, NovaMedica, Eirion Therapeutics, Inc, Roivant Sciences Ltd, GSK Plc, GlaxoSmithKline PLC and Sesderma
Key Developments:
In Jan 2023, AbbVie and Anima Biotech Announce Collaboration for the Discovery and Development of mRNA Biology Modulators against Oncology and Immunology Targets, Anima will use its mRNA Lightning platform to discover novel mRNA biology modulators against the collaboration targets providing AbbVie exclusive rights to license and further develop and commercialize the programs.
In Dec 2022, AbbVie Launches Strategic Collaboration with HotSpot Therapeutics to Further Expand Immunology Pipeline this collaboration with HotSpot has the potential to deliver an entirely new target class of modulators to patients with serious autoimmune diseases
In Dec 2022, Dermavant Launched First Commercial for VTAMA® (tapinarof) cream, 1% as Part of a National, Multimedia Campaign for Adults with Plaque Psoriasis many have been waiting a long time for a different plaque psoriasis treatment like VTAMA cream.
In June 2022, Dermata Announces Final Patient Enrolled in a Phase 2 Trial of DMT310 for the Once-Weekly Treatment of Moderate-to-Severe Rosacea, DMT310 is currently being investigated to treat multiple inflammatory skin conditions, including rosacea, acne, and psoriasis.
Treatment Types Covered:
- Surgical Treatments
- Topical Treatments
- Botulin Toxin A
- Laser Treatments
- Iontophoresis
- Other Treatment Types
Disease Types Covered:
- Primary Focal Hyperhidrosis
- Secondary Generalized Hyperhidrosis
End Users Covered:
- Hospitals
- Homecare
- Speciality Centres
- Other End Users
Regions Covered:
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
- South America
- Argentina
- Brazil
- Chile
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
- Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
- Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
- Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
- 2.1 Abstract
- 2.2 Stake Holders
- 2.3 Research Scope
- 2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
- 2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions
3 Market Trend Analysis
- 3.1 Introduction
- 3.2 Drivers
- 3.3 Restraints
- 3.4 Opportunities
- 3.5 Threats
- 3.6 End User Analysis
- 3.7 Emerging Markets
- 3.8 Impact of Covid-19
4 Porters Five Force Analysis
- 4.1 Bargaining power of suppliers
- 4.2 Bargaining power of buyers
- 4.3 Threat of substitutes
- 4.4 Threat of new entrants
- 4.5 Competitive rivalry
5 Global Hyperhidrosis Treatment Market, By Treatment Type
- 5.1 Introduction
- 5.2 Surgical Treatments
- 5.3 Topical Treatments
- 5.4 Botulin Toxin A
- 5.5 Laser Treatments
- 5.6 Iontophoresis
- 5.7 Other Treatment Types
6 Global Hyperhidrosis Treatment Market, By Disease Type
- 6.1 Introduction
- 6.2 Primary Focal Hyperhidrosis
- 6.3 Secondary Generalized Hyperhidrosis
7 Global Hyperhidrosis Treatment Market, By End User
- 7.1 Introduction
- 7.2 Hospitals
- 7.3 Homecare
- 7.4 Speciality Centres
- 7.5 Other End Users
8 Global Hyperhidrosis Treatment Market, By Geography
- 8.1 Introduction
- 8.2 North America
- 8.2.1 US
- 8.2.2 Canada
- 8.2.3 Mexico
- 8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 Italy
- 8.3.4 France
- 8.3.5 Spain
- 8.3.6 Rest of Europe
- 8.4 Asia Pacific
- 8.4.1 Japan
- 8.4.2 China
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 New Zealand
- 8.4.6 South Korea
- 8.4.7 Rest of Asia Pacific
- 8.5 South America
- 8.5.1 Argentina
- 8.5.2 Brazil
- 8.5.3 Chile
- 8.5.4 Rest of South America
- 8.6 Middle East & Africa
- 8.6.1 Saudi Arabia
- 8.6.2 UAE
- 8.6.3 Qatar
- 8.6.4 South Africa
- 8.6.5 Rest of Middle East & Africa
9 Key Developments
- 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
- 9.2 Acquisitions & Mergers
- 9.3 New Product Launch
- 9.4 Expansions
- 9.5 Other Key Strategies
10 Company Profiling
- 10.1 Brickell Biotech Inc.
- 10.2 Eli Lilly and Company
- 10.3 AbbVie Inc
- 10.4 1315 Capital
- 10.5 Merz Pharma
- 10.6 Dermadry Laboratories Inc.
- 10.7 Dermata Therapeutics Inc.
- 10.8 Advin Health Care
- 10.9 Dermavant Sciences Inc.
- 10.10 TheraVida
- 10.11 NovaMedica
- 10.12 Eirion Therapeutics, Inc
- 10.13 Roivant Sciences Ltd
- 10.14 GSK Plc
- 10.15 GlaxoSmithKline PLC
- 10.16 Sesderma
List of Tables
- Table 1 Global Hyperhidrosis Treatment Market Outlook, By Region (2020-2028) ($MN)
- Table 2 Global Hyperhidrosis Treatment Market Outlook, By Treatment Type (2020-2028) ($MN)
- Table 3 Global Hyperhidrosis Treatment Market Outlook, By Surgical Treatments (2020-2028) ($MN)
- Table 4 Global Hyperhidrosis Treatment Market Outlook, By Topical Treatments (2020-2028) ($MN)
- Table 5 Global Hyperhidrosis Treatment Market Outlook, By Botulin Toxin A (2020-2028) ($MN)
- Table 6 Global Hyperhidrosis Treatment Market Outlook, By Laser Treatments (2020-2028) ($MN)
- Table 7 Global Hyperhidrosis Treatment Market Outlook, By Iontophoresis (2020-2028) ($MN)
- Table 8 Global Hyperhidrosis Treatment Market Outlook, By Other Treatment Types (2020-2028) ($MN)
- Table 9 Global Hyperhidrosis Treatment Market Outlook, By Disease Type (2020-2028) ($MN)
- Table 10 Global Hyperhidrosis Treatment Market Outlook, By Primary Focal Hyperhidrosis (2020-2028) ($MN)
- Table 11 Global Hyperhidrosis Treatment Market Outlook, By Secondary Generalized Hyperhidrosis (2020-2028) ($MN)
- Table 12 Global Hyperhidrosis Treatment Market Outlook, By End User (2020-2028) ($MN)
- Table 13 Global Hyperhidrosis Treatment Market Outlook, By Hospitals (2020-2028) ($MN)
- Table 14 Global Hyperhidrosis Treatment Market Outlook, By Homecare (2020-2028) ($MN)
- Table 15 Global Hyperhidrosis Treatment Market Outlook, By Speciality Centres (2020-2028) ($MN)
- Table 16 Global Hyperhidrosis Treatment Market Outlook, By Other End Users (2020-2028) ($MN)
- Table 17 North America Hyperhidrosis Treatment Market Outlook, By Country (2020-2028) ($MN)
- Table 18 North America Hyperhidrosis Treatment Market Outlook, By Treatment Type (2020-2028) ($MN)
- Table 19 North America Hyperhidrosis Treatment Market Outlook, By Surgical Treatments (2020-2028) ($MN)
- Table 20 North America Hyperhidrosis Treatment Market Outlook, By Topical Treatments (2020-2028) ($MN)
- Table 21 North America Hyperhidrosis Treatment Market Outlook, By Botulin Toxin A (2020-2028) ($MN)
- Table 22 North America Hyperhidrosis Treatment Market Outlook, By Laser Treatments (2020-2028) ($MN)
- Table 23 North America Hyperhidrosis Treatment Market Outlook, By Iontophoresis (2020-2028) ($MN)
- Table 24 North America Hyperhidrosis Treatment Market Outlook, By Other Treatment Types (2020-2028) ($MN)
- Table 25 North America Hyperhidrosis Treatment Market Outlook, By Disease Type (2020-2028) ($MN)
- Table 26 North America Hyperhidrosis Treatment Market Outlook, By Primary Focal Hyperhidrosis (2020-2028) ($MN)
- Table 27 North America Hyperhidrosis Treatment Market Outlook, By Secondary Generalized Hyperhidrosis (2020-2028) ($MN)
- Table 28 North America Hyperhidrosis Treatment Market Outlook, By End User (2020-2028) ($MN)
- Table 29 North America Hyperhidrosis Treatment Market Outlook, By Hospitals (2020-2028) ($MN)
- Table 30 North America Hyperhidrosis Treatment Market Outlook, By Homecare (2020-2028) ($MN)
- Table 31 North America Hyperhidrosis Treatment Market Outlook, By Speciality Centres (2020-2028) ($MN)
- Table 32 North America Hyperhidrosis Treatment Market Outlook, By Other End Users (2020-2028) ($MN)
- Table 33 Europe Hyperhidrosis Treatment Market Outlook, By Country (2020-2028) ($MN)
- Table 34 Europe Hyperhidrosis Treatment Market Outlook, By Treatment Type (2020-2028) ($MN)
- Table 35 Europe Hyperhidrosis Treatment Market Outlook, By Surgical Treatments (2020-2028) ($MN)
- Table 36 Europe Hyperhidrosis Treatment Market Outlook, By Topical Treatments (2020-2028) ($MN)
- Table 37 Europe Hyperhidrosis Treatment Market Outlook, By Botulin Toxin A (2020-2028) ($MN)
- Table 38 Europe Hyperhidrosis Treatment Market Outlook, By Laser Treatments (2020-2028) ($MN)
- Table 39 Europe Hyperhidrosis Treatment Market Outlook, By Iontophoresis (2020-2028) ($MN)
- Table 40 Europe Hyperhidrosis Treatment Market Outlook, By Other Treatment Types (2020-2028) ($MN)
- Table 41 Europe Hyperhidrosis Treatment Market Outlook, By Disease Type (2020-2028) ($MN)
- Table 42 Europe Hyperhidrosis Treatment Market Outlook, By Primary Focal Hyperhidrosis (2020-2028) ($MN)
- Table 43 Europe Hyperhidrosis Treatment Market Outlook, By Secondary Generalized Hyperhidrosis (2020-2028) ($MN)
- Table 44 Europe Hyperhidrosis Treatment Market Outlook, By End User (2020-2028) ($MN)
- Table 45 Europe Hyperhidrosis Treatment Market Outlook, By Hospitals (2020-2028) ($MN)
- Table 46 Europe Hyperhidrosis Treatment Market Outlook, By Homecare (2020-2028) ($MN)
- Table 47 Europe Hyperhidrosis Treatment Market Outlook, By Speciality Centres (2020-2028) ($MN)
- Table 48 Europe Hyperhidrosis Treatment Market Outlook, By Other End Users (2020-2028) ($MN)
- Table 49 Asia Pacific Hyperhidrosis Treatment Market Outlook, By Country (2020-2028) ($MN)
- Table 50 Asia Pacific Hyperhidrosis Treatment Market Outlook, By Treatment Type (2020-2028) ($MN)
- Table 51 Asia Pacific Hyperhidrosis Treatment Market Outlook, By Surgical Treatments (2020-2028) ($MN)
- Table 52 Asia Pacific Hyperhidrosis Treatment Market Outlook, By Topical Treatments (2020-2028) ($MN)
- Table 53 Asia Pacific Hyperhidrosis Treatment Market Outlook, By Botulin Toxin A (2020-2028) ($MN)
- Table 54 Asia Pacific Hyperhidrosis Treatment Market Outlook, By Laser Treatments (2020-2028) ($MN)
- Table 55 Asia Pacific Hyperhidrosis Treatment Market Outlook, By Iontophoresis (2020-2028) ($MN)
- Table 56 Asia Pacific Hyperhidrosis Treatment Market Outlook, By Other Treatment Types (2020-2028) ($MN)
- Table 57 Asia Pacific Hyperhidrosis Treatment Market Outlook, By Disease Type (2020-2028) ($MN)
- Table 58 Asia Pacific Hyperhidrosis Treatment Market Outlook, By Primary Focal Hyperhidrosis (2020-2028) ($MN)
- Table 59 Asia Pacific Hyperhidrosis Treatment Market Outlook, By Secondary Generalized Hyperhidrosis (2020-2028) ($MN)
- Table 60 Asia Pacific Hyperhidrosis Treatment Market Outlook, By End User (2020-2028) ($MN)
- Table 61 Asia Pacific Hyperhidrosis Treatment Market Outlook, By Hospitals (2020-2028) ($MN)
- Table 62 Asia Pacific Hyperhidrosis Treatment Market Outlook, By Homecare (2020-2028) ($MN)
- Table 63 Asia Pacific Hyperhidrosis Treatment Market Outlook, By Speciality Centres (2020-2028) ($MN)
- Table 64 Asia Pacific Hyperhidrosis Treatment Market Outlook, By Other End Users (2020-2028) ($MN)
- Table 65 South America Hyperhidrosis Treatment Market Outlook, By Country (2020-2028) ($MN)
- Table 66 South America Hyperhidrosis Treatment Market Outlook, By Treatment Type (2020-2028) ($MN)
- Table 67 South America Hyperhidrosis Treatment Market Outlook, By Surgical Treatments (2020-2028) ($MN)
- Table 68 South America Hyperhidrosis Treatment Market Outlook, By Topical Treatments (2020-2028) ($MN)
- Table 69 South America Hyperhidrosis Treatment Market Outlook, By Botulin Toxin A (2020-2028) ($MN)
- Table 70 South America Hyperhidrosis Treatment Market Outlook, By Laser Treatments (2020-2028) ($MN)
- Table 71 South America Hyperhidrosis Treatment Market Outlook, By Iontophoresis (2020-2028) ($MN)
- Table 72 South America Hyperhidrosis Treatment Market Outlook, By Other Treatment Types (2020-2028) ($MN)
- Table 73 South America Hyperhidrosis Treatment Market Outlook, By Disease Type (2020-2028) ($MN)
- Table 74 South America Hyperhidrosis Treatment Market Outlook, By Primary Focal Hyperhidrosis (2020-2028) ($MN)
- Table 75 South America Hyperhidrosis Treatment Market Outlook, By Secondary Generalized Hyperhidrosis (2020-2028) ($MN)
- Table 76 South America Hyperhidrosis Treatment Market Outlook, By End User (2020-2028) ($MN)
- Table 77 South America Hyperhidrosis Treatment Market Outlook, By Hospitals (2020-2028) ($MN)
- Table 78 South America Hyperhidrosis Treatment Market Outlook, By Homecare (2020-2028) ($MN)
- Table 79 South America Hyperhidrosis Treatment Market Outlook, By Speciality Centres (2020-2028) ($MN)
- Table 80 South America Hyperhidrosis Treatment Market Outlook, By Other End Users (2020-2028) ($MN)
- Table 81 Middle East & Africa Hyperhidrosis Treatment Market Outlook, By Country (2020-2028) ($MN)
- Table 82 Middle East & Africa Hyperhidrosis Treatment Market Outlook, By Treatment Type (2020-2028) ($MN)
- Table 83 Middle East & Africa Hyperhidrosis Treatment Market Outlook, By Surgical Treatments (2020-2028) ($MN)
- Table 84 Middle East & Africa Hyperhidrosis Treatment Market Outlook, By Topical Treatments (2020-2028) ($MN)
- Table 85 Middle East & Africa Hyperhidrosis Treatment Market Outlook, By Botulin Toxin A (2020-2028) ($MN)
- Table 86 Middle East & Africa Hyperhidrosis Treatment Market Outlook, By Laser Treatments (2020-2028) ($MN)
- Table 87 Middle East & Africa Hyperhidrosis Treatment Market Outlook, By Iontophoresis (2020-2028) ($MN)
- Table 88 Middle East & Africa Hyperhidrosis Treatment Market Outlook, By Other Treatment Types (2020-2028) ($MN)
- Table 89 Middle East & Africa Hyperhidrosis Treatment Market Outlook, By Disease Type (2020-2028) ($MN)
- Table 90 Middle East & Africa Hyperhidrosis Treatment Market Outlook, By Primary Focal Hyperhidrosis (2020-2028) ($MN)
- Table 91 Middle East & Africa Hyperhidrosis Treatment Market Outlook, By Secondary Generalized Hyperhidrosis (2020-2028) ($MN)
- Table 92 Middle East & Africa Hyperhidrosis Treatment Market Outlook, By End User (2020-2028) ($MN)
- Table 93 Middle East & Africa Hyperhidrosis Treatment Market Outlook, By Hospitals (2020-2028) ($MN)
- Table 94 Middle East & Africa Hyperhidrosis Treatment Market Outlook, By Homecare (2020-2028) ($MN)
- Table 95 Middle East & Africa Hyperhidrosis Treatment Market Outlook, By Speciality Centres (2020-2028) ($MN)
- Table 96 Middle East & Africa Hyperhidrosis Treatment Market Outlook, By Other End Users (2020-2028) ($MN)
